These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 12173729

  • 1. Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.
    Drent ML, Tollefsen AT, van Heusden FH, Hoenderdos EB, Jonker JJ, van der Veen EA.
    Diabetes Nutr Metab; 2002 Jun; 15(3):152-9. PubMed ID: 12173729
    [Abstract] [Full Text] [Related]

  • 2. Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.
    Johnston PS, Feig PU, Coniff RF, Krol A, Davidson JA, Haffner SM.
    Diabetes Care; 1998 Mar; 21(3):409-15. PubMed ID: 9540024
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.
    Segal P, Feig PU, Schernthaner G, Ratzmann KP, Rybka J, Petzinna D, Berlin C.
    Diabetes Care; 1997 May; 20(5):687-91. PubMed ID: 9135927
    [Abstract] [Full Text] [Related]

  • 5. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.
    Johnston PS, Lebovitz HE, Coniff RF, Simonson DC, Raskin P, Munera CL.
    J Clin Endocrinol Metab; 1998 May; 83(5):1515-22. PubMed ID: 9589648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.
    Mitrakou A, Tountas N, Raptis AE, Bauer RJ, Schulz H, Raptis SA.
    Diabet Med; 1998 Aug; 15(8):657-60. PubMed ID: 9702468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office].
    Fehmann HC.
    Fortschr Med Orig; 2001 Jul 19; 119 Suppl 2():55-61. PubMed ID: 15704357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.
    Chiasson JL, Naditch L, Miglitol Canadian University Investigator Group.
    Diabetes Care; 2001 Jun 19; 24(6):989-94. PubMed ID: 11375358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.
    Schnack C, Prager RJ, Winkler J, Klauser RM, Schneider BG, Schernthaner G.
    Diabetes Care; 1989 Sep 19; 12(8):537-43. PubMed ID: 2673693
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.
    Standl E, Schernthaner G, Rybka J, Hanefeld M, Raptis SA, Naditch L.
    Diabetes Res Clin Pract; 2001 Mar 19; 51(3):205-13. PubMed ID: 11269893
    [Abstract] [Full Text] [Related]

  • 17. Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes.
    Heinz G, Komjati M, Korn A, Waldhäusl W.
    Eur J Clin Pharmacol; 1989 Mar 19; 37(1):33-6. PubMed ID: 2687007
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office].
    Fehmann HC.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():55-61. PubMed ID: 15700487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alpha glucosidase inhibition in the treatment of non-insulin-dependent diabetes mellitus.
    Scott AR, Tattersall RB.
    Diabet Med; 1988 Jan 27; 5(1):42-6. PubMed ID: 2964327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.